The European Medicines Agency (EMA) has released an updated draft guideline on medicines for the treatment of Alzheimer’s Disease and other types of dementia, for consultative feedback.
Consultation on revised guideline on medicines to treat Alzheimer’s disease. [Online]: European Medicines Agency, February 1st 2016.
This relates to:
Draft guideline on the clinical investigation of medicines for the treatment of Alzheimer’s disease and other dementias. London: European Medicines Agency; Committee for Medicinal Products for Human Use (CHMP), [January 28th 2016] February 1st 2016.